Why GE HealthCare Technologies Stock Soared More Than 24% in February

04.03.24 13:21 Uhr

Werte in diesem Artikel
Aktien

79,10 EUR -1,36 EUR -1,69%

Indizes

4.967,2 PKT -43,9 PKT -0,88%

Shares in leading healthcare company GE HealthCare Technologies (NASDAQ: GEHC) soared by 24.4% in February, according to data provided by S&P Global Market Intelligence. There's little doubt over the catalyst for the move; it comes from an excellent earnings report released in the first week of the month.The investment case for GE HealthCare is based on the idea that, now that it's a stand-alone company, management is free to realize its full potential. That potential lies in optimizing its pricing and product portfolio, researching and developing new products, building out its artificial intelligence (AI) backed solutions, selective mergers and acquisitions activity, and growing in exciting growth markets where it has a natural edge.One example of the latter comes from the growing theranostics market. In this medical technique, one radiopharmaceutical drug is used to diagnose and monitor an affected area (such as an area with cancer cells). Meanwhile, another drug targets and treats the area precisely, producing better patient outcomes.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Ausgewählte Hebelprodukte auf GE HealthCare Technologies

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf GE HealthCare Technologies

NameHebelKOEmittent
NameHebelKOEmittent
Werbung

Quelle: MotleyFool

Nachrichten zu GE HealthCare Technologies